Q. Molenaar

University Medical Center Utrecht

Papers

9

Total Citations

352

H-Index

9

About

Dr. Q. Molenaar is a leading surgical oncologist whose research focuses on advancing minimally invasive techniques for pancreatic and liver surgery, with a particular emphasis on improving outcomes for patients with pancreatic cancer. Their most impactful contribution is the landmark DIPLOMA trial (2023, 121 citations), the first international randomized non-inferiority study comparing minimally invasive distal pancreatectomy (MIDP) to open surgery for resectable pancreatic cancer—a pivotal work that addresses longstanding oncological safety concerns. Dr. Molenaar has also driven the nationwide implementation and benchmarking of robotic liver surgery in the Netherlands (2022, 41 citations) and robotic distal pancreatectomy (2023, 41 citations), establishing quality standards through multicenter European benchmarking studies (2022, 29–32 citations). Their leadership of the LAELAPS-3 training program (2020, 31 citations) has been instrumental in safely disseminating robotic pancreatoduodenectomy skills across centers. With a research portfolio that spans from randomized trials to implementation science, Dr. Molenaar’s work has directly shaped international guidelines and surgical practice, demonstrating that minimally invasive approaches can be both safe and effective for complex pancreatic resections.

Research Focus

Key Achievements

9
H-Index
9
Papers
352
Total Citations
39
Avg Citations/Paper
🏆 Most Cited Paper
Minimally invasive versus open distal pancreatectomy for resectable pancreatic cancer (DIPLOMA): an international randomised non-inferiority trial
121 citations · 2023
📈 Most Prolific Year: 2023 (3 Papers)
🤝 Key Collaborators: 178
🏛 Institutions: University Medical Center Utrecht

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago